XML 95 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - CAD ($)
Total
Common shares (Note 15)
Issued capital
Preferred shares (Note 15)
Issued capital
Common shares (Note 15)
Contributed surplus
Retained earnings
Retained earnings
Preferred shares (Note 15)
Retained earnings
Common shares (Note 15)
Accumulated other comprehensive income (loss), net of taxes (Note 27)
Total shareholders' equity
Non-controlling interests’ equity
Participating policyholders
Changes in equity [abstract]                        
Adjustment for change in accounting policy (Note 2)           $ (44,000,000)            
Balance, beginning of year, after change in accounting policy           10,261,000,000            
Equity, beginning of year at Dec. 31, 2017     $ 2,257,000,000 $ 8,582,000,000 $ 72,000,000 10,305,000,000     $ 1,105,000,000   $ 0 $ 650,000,000
Changes in equity [abstract]                        
Stock options exercised   $ 16,000,000   16,000,000 (3,000,000)              
Common shares purchased for cancellation   (183,000,000)   (183,000,000)   (458,000,000)            
Common shares issued as consideration for business acquisition $ (4,000,000)     (4,000,000)                
Share-based payments         4,000,000              
Net income (loss) 2,914,000,000         2,616,000,000         0 298,000,000
Dividends on shares             $ (94,000,000) $ (1,147,000,000)        
Transfer to (from) within equity                       (89,000,000)
Transfer from participating policyholders’ equity (Note 21)           (89,000,000)            
Changes attributable to acquisition (Note 3)           0         0  
Equity, end of year at Dec. 31, 2018 24,570,000,000 21,449,000,000 2,257,000,000 8,419,000,000 73,000,000 11,267,000,000     1,690,000,000 $ 23,706,000,000 0 864,000,000
Changes in equity [abstract]                        
Total other comprehensive income (loss) for the year 590,000,000               585,000,000 585,000,000   5,000,000
Adjustment for change in accounting policy (Note 2)           (22,000,000)            
Balance, beginning of year, after change in accounting policy           11,245,000,000            
Stock options exercised   28,000,000   28,000,000 (5,000,000)              
Common shares purchased for cancellation   (158,000,000)   (158,000,000)   (434,000,000)            
Common shares issued as consideration for business acquisition 0     0                
Share-based payments         5,000,000              
Net income (loss) 2,947,000,000         2,713,000,000         4,000,000 230,000,000
Dividends on shares             $ (95,000,000) $ (1,236,000,000)        
Transfer to (from) within equity                       0
Transfer from participating policyholders’ equity (Note 21)           0            
Changes attributable to acquisition (Note 3)           (875,000,000)         15,000,000  
Equity, end of year at Dec. 31, 2019 24,508,000,000 $ 21,141,000,000 $ 2,257,000,000 $ 8,289,000,000 $ 73,000,000 $ 11,318,000,000     1,461,000,000 23,398,000,000 $ 19,000,000 1,091,000,000
Changes in equity [abstract]                        
Total other comprehensive income (loss) for the year $ (232,000,000)               $ (229,000,000) $ (229,000,000)   $ (3,000,000)